Yearly Publication Trends - essential thrombocythemia

Year	Publication Count
2024	118
2023	289
2022	150
2021	175
2020	127
2019	144
2018	52
2017	70
2016	75
2015	61
2014	63

Relevant Publications

A 1-year-old child with essential thrombocythemia.

Issue Release: 2024

Assessment of Total Antioxidant Capacity, 8-Hydroxy-2\'-deoxy-guanosine, the Genetic Landscape, and Their Associations in -Negative Chronic and Blast Phase Myeloproliferative Neoplasms.

Issue Release: 2024

Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ.

Issue Release: 2024

[Recent findings and advances in treatment of myeloproliferative neoplasms].

Issue Release: 2024

Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.

Issue Release: 2024

Essential thrombocythemia: nutritional management in weight loss and malnutrition.

Issue Release: 2024

Management of Essential Thrombocythemia in a Patient With a History of Thrombotic Thrombocytopenic Purpura.

Issue Release: 2024

Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia.

Issue Release: 2024

Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.

Issue Release: 2024

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis.

Issue Release: 2024

Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis.

Issue Release: 2024

Digital gangrene: can be the first manifestation of essential thrombocythemia? a case report.

Issue Release: 2024

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.

Issue Release: 2024

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.

Issue Release: 2024

Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia.

Issue Release: 2024

SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis.

Issue Release: 2024

[Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms].

Issue Release: 2024

[Comparison of Clinical Characteristics of and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia].

Issue Release: 2024

Childbirth rates in women with myeloproliferative neoplasms.

Issue Release: 2024

A rare case of essential thrombocythemia with pseudo-hyperkalemia.

Issue Release: 2024

What Are the Current Challenges in Targeting Curl?

What is Diagnostic Surgery?

What Technologies Aid in Improving Adherence?

Who is a Candidate for Locoregional Therapy?

How Can Patients Prepare for Treatment?

What is Troponin?

Can Cancer Patients Get Term Life Insurance?

What are the advantages of Lapatinib over other treatments?

What Are the Safety Concerns Associated with SWCNTs?

Can a Hydatidiform Mole Be Prevented?

Yearly Publication Trends - essential thrombocythemia

Relevant Publications

Relevant Topics

Partnered Content Networks

Relevant Topics